|
US4714680B1
(en)
|
1984-02-06 |
1995-06-27 |
Univ Johns Hopkins |
Human stem cells
|
|
US4965204A
(en)
|
1984-02-06 |
1990-10-23 |
The Johns Hopkins University |
Human stem cells and monoclonal antibodies
|
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
|
JP3022967B2
(ja)
|
1985-03-15 |
2000-03-21 |
アンチバイラルズ インコーポレイテッド |
立体規則性ポリヌクレオチド結合ポリマー
|
|
US5217866A
(en)
|
1985-03-15 |
1993-06-08 |
Anti-Gene Development Group |
Polynucleotide assay reagent and method
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
US5521063A
(en)
|
1985-03-15 |
1996-05-28 |
Antivirals Inc. |
Polynucleotide reagent containing chiral subunits and methods of use
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
US5422251A
(en)
|
1986-11-26 |
1995-06-06 |
Princeton University |
Triple-stranded nucleic acids
|
|
US4812397A
(en)
|
1987-02-10 |
1989-03-14 |
The Regents Of The University Of California |
MAB-anti-DNA related to nephritis
|
|
US5061620A
(en)
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
|
US6441130B1
(en)
|
1991-05-24 |
2002-08-27 |
Isis Pharmaceuticals, Inc. |
Linked peptide nucleic acids
|
|
US5714331A
(en)
|
1991-05-24 |
1998-02-03 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
|
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
|
US5356802A
(en)
|
1992-04-03 |
1994-10-18 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease
|
|
US5436150A
(en)
|
1992-04-03 |
1995-07-25 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
|
|
US5487994A
(en)
|
1992-04-03 |
1996-01-30 |
The Johns Hopkins University |
Insertion and deletion mutants of FokI restriction endonuclease
|
|
JPH09503644A
(ja)
|
1993-06-25 |
1997-04-15 |
エール ユニバーシティ |
部位特異的変異誘発のための化学的に修飾されたオリゴヌクレオチド
|
|
US5962426A
(en)
|
1993-06-25 |
1999-10-05 |
Yale University |
Triple-helix forming oligonucleotides for targeted mutagenesis
|
|
US5527675A
(en)
|
1993-08-20 |
1996-06-18 |
Millipore Corporation |
Method for degradation and sequencing of polymers which sequentially eliminate terminal residues
|
|
DE4331012A1
(de)
|
1993-09-13 |
1995-03-16 |
Bayer Ag |
Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik
|
|
US5409813A
(en)
|
1993-09-30 |
1995-04-25 |
Systemix, Inc. |
Method for mammalian cell separation from a mixture of cell populations
|
|
US5677136A
(en)
|
1994-11-14 |
1997-10-14 |
Systemix, Inc. |
Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
|
|
WO1996039195A2
(en)
|
1995-06-06 |
1996-12-12 |
Yale University |
Chemically modified oligonucleotide for site-directed mutagenesis
|
|
US7279463B2
(en)
|
1995-06-07 |
2007-10-09 |
Yale University |
Triple-helix forming oligonucleotides for targeted mutagenesis
|
|
WO1996040271A1
(en)
|
1995-06-07 |
1996-12-19 |
Yale University |
Treatment of hemoglobinopathies
|
|
WO1997032602A1
(en)
|
1996-03-08 |
1997-09-12 |
The Regents Of The University Of California |
DELIVERY SYSTEM USING mAb 3E10 AND MUTANTS AND/OR FUNCTIONAL FRAGMENTS THEREOF
|
|
US5945337A
(en)
|
1996-10-18 |
1999-08-31 |
Quality Biological, Inc. |
Method for culturing CD34+ cells in a serum-free medium
|
|
US5786571A
(en)
|
1997-05-09 |
1998-07-28 |
Lexmark International, Inc. |
Wrapped temperature sensing assembly
|
|
GB9710807D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
US6326479B1
(en)
|
1998-01-27 |
2001-12-04 |
Boston Probes, Inc. |
Synthetic polymers and methods, kits or compositions for modulating the solubility of same
|
|
US6140081A
(en)
|
1998-10-16 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger binding domains for GNN
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
AU5886000A
(en)
|
1999-06-25 |
2001-01-31 |
Northwestern University |
Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells
|
|
US6919208B2
(en)
|
2000-05-22 |
2005-07-19 |
The Children's Hospital Of Philadelphia |
Methods and compositions for enhancing the delivery of a nucleic acid to a cell
|
|
US20040259247A1
(en)
|
2000-12-01 |
2004-12-23 |
Thomas Tuschl |
Rna interference mediating small rna molecules
|
|
US7067617B2
(en)
|
2001-02-21 |
2006-06-27 |
The Scripps Research Institute |
Zinc finger binding domains for nucleotide sequence ANN
|
|
US20040197892A1
(en)
|
2001-04-04 |
2004-10-07 |
Michael Moore |
Composition binding polypeptides
|
|
WO2002094983A2
(en)
|
2001-05-16 |
2002-11-28 |
The Children's Hospital Of Philadelphia |
Dna-antibody complexes to enhance gene transfer
|
|
US20040224385A1
(en)
|
2001-08-20 |
2004-11-11 |
Barbas Carlos F |
Zinc finger binding domains for cnn
|
|
EP1468086A2
(en)
|
2001-12-14 |
2004-10-20 |
Yale University |
INTRACELLULAR GENERATION OF SINGLE−STRANDED DNA
|
|
DE102004042546A1
(de)
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
|
US20070036773A1
(en)
*
|
2005-08-09 |
2007-02-15 |
City Of Hope |
Generation and application of universal T cells for B-ALL
|
|
US8658608B2
(en)
|
2005-11-23 |
2014-02-25 |
Yale University |
Modified triple-helix forming oligonucleotides for targeted mutagenesis
|
|
JP2009520463A
(ja)
|
2005-11-28 |
2009-05-28 |
ザ スクリプス リサーチ インスティテュート |
Ｔｎｎのための亜鉛フィンガー結合ドメイン
|
|
WO2007081647A2
(en)
|
2006-01-03 |
2007-07-19 |
The Scripps Research Institute |
Zinc finger domains specifically binding agc
|
|
CN1986792A
(zh)
|
2006-12-14 |
2007-06-27 |
方炳良 |
致病细胞的外来抗原标记方法
|
|
JP2010515464A
(ja)
|
2007-01-11 |
2010-05-13 |
イエール・ユニバーシテイ |
Ｈｉｖ細胞表面受容体の標的化不活性化のための組成物および方法
|
|
WO2008091911A2
(en)
|
2007-01-22 |
2008-07-31 |
The Regents Of The University Of California |
Use of antibody conjugates
|
|
EP3486653A1
(en)
|
2007-05-24 |
2019-05-22 |
The United States Government as represented by The Department of Veterans Affairs |
Treatment of skeletal muscle disorder using ent2
|
|
US8609615B2
(en)
*
|
2008-10-15 |
2013-12-17 |
Valerion Therapeutics, Llc |
Methods and compositions for treatment of myotonic dystrophy
|
|
US8309356B2
(en)
|
2009-04-01 |
2012-11-13 |
Yale University |
Pseudocomplementary oligonucleotides for targeted gene therapy
|
|
WO2010123983A1
(en)
|
2009-04-21 |
2010-10-28 |
Yale University |
Compostions and methods for targeted gene therapy
|
|
US9155801B2
(en)
*
|
2009-05-28 |
2015-10-13 |
The United States Government As Represented By The Department Of Veterans Affairs |
Amino acid sequences which enhance peptide conjugate solubility
|
|
AU2010260145B2
(en)
|
2009-06-15 |
2015-08-20 |
Valerion Therapeutics, Llc |
Methods and compositions for treatment of Myotubular Myopathy using chimeric polypeptides comprising myotubularin 1 (MTM1) polypeptides
|
|
US20110268810A1
(en)
|
2009-11-02 |
2011-11-03 |
Yale University |
Polymeric materials loaded with mutagenic and recombinagenic nucleic acids
|
|
HUE041436T2
(hu)
|
2009-12-10 |
2019-05-28 |
Univ Minnesota |
Tal-effektor-közvetített DNS-módosítás
|
|
WO2011133802A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
|
WO2011133803A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
|
EP3597665A1
(en)
*
|
2011-04-01 |
2020-01-22 |
Yale University, Inc. |
Cell-penetrating anti-dna antibodies and uses thereof to inhibit dna repair
|
|
CN107164330A
(zh)
|
2011-04-08 |
2017-09-15 |
贝勒医学院 |
使用嵌合细胞因子受体逆转肿瘤微环境的影响
|
|
EP3428287B1
(en)
|
2011-04-08 |
2021-03-24 |
Carnegie Mellon University |
Conformationally-preorganized, minipeg-containing gamma-peptide nucleic acids
|
|
US20130071414A1
(en)
|
2011-04-27 |
2013-03-21 |
Gianpietro Dotti |
Engineered cd19-specific t lymphocytes that coexpress il-15 and an inducible caspase-9 based suicide gene for the treatment of b-cell malignancies
|
|
US9272043B2
(en)
|
2011-12-02 |
2016-03-01 |
Yale University |
Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
|
|
WO2013082529A1
(en)
|
2011-12-02 |
2013-06-06 |
Yale University |
Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
|
|
US9610362B2
(en)
|
2012-03-16 |
2017-04-04 |
Valerion Therapeutics, Llc |
Antisense conjugates for decreasing expression of DMPK
|
|
US9732146B2
(en)
|
2012-03-30 |
2017-08-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Antibody-mediated transduction of heat shock proteins into living cells
|
|
US9283272B2
(en)
|
2012-03-30 |
2016-03-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Targeting intracellular target-binding determinants with intracellular antibodies
|
|
EP3241902B1
(en)
|
2012-05-25 |
2018-02-28 |
The Regents of The University of California |
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
|
|
US20150290244A1
(en)
|
2012-07-13 |
2015-10-15 |
The Trustees Of The University Of Pennsylvania |
Use of cart19 to deplete normal b cells to induce tolerance
|
|
KR102530118B1
(ko)
|
2012-07-25 |
2023-05-08 |
더 브로드 인스티튜트, 인코퍼레이티드 |
유도 ｄｎａ 결합 단백질 및 게놈 교란 도구 및 이의 적용
|
|
EP2981551B1
(en)
|
2013-02-20 |
2020-06-03 |
Valerion Therapeutics, LLC |
Methods and compositions for treatment of pompe disease
|
|
WO2014201378A1
(en)
|
2013-06-13 |
2014-12-18 |
Massachusetts Institute Of Technology |
Synergistic tumor treatment with extended-pk il -2 and adoptive cell therapy
|
|
EP3094646B1
(en)
|
2014-01-13 |
2020-04-15 |
Valerion Therapeutics, LLC |
Internalizing moieties
|
|
US10040867B2
(en)
|
2014-03-04 |
2018-08-07 |
Yale University |
Cell penetrating anti-guanosine antibody based therapy for cancers with Ras mutations
|
|
BR112016019940A2
(pt)
|
2014-03-21 |
2017-10-24 |
Univ Leland Stanford Junior |
edição de genoma sem nucleases
|
|
AU2015244039B2
(en)
|
2014-04-07 |
2021-10-21 |
Novartis Ag |
Treatment of cancer using anti-CD19 chimeric antigen receptor
|
|
US10202591B2
(en)
|
2014-06-13 |
2019-02-12 |
Valerion Therapeutics, Llc |
Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders
|
|
CA2995673A1
(en)
|
2014-08-27 |
2016-03-03 |
Valerion Therapeutics, Llc |
Internalizing moieties for treatment of cancer
|
|
EP3194450A1
(en)
|
2014-08-28 |
2017-07-26 |
Yale University |
Multivalent fragments of antibody 3e10 and methods of use thereof
|
|
WO2016081621A1
(en)
|
2014-11-18 |
2016-05-26 |
Yale University |
Formulations for targeted release of agents under low ph conditions and methods of use thereof
|
|
WO2017015101A1
(en)
|
2015-07-17 |
2017-01-26 |
University Of Washington |
Methods for maximizing the efficiency of targeted gene correction
|
|
EP3325505B1
(en)
|
2015-07-23 |
2020-08-19 |
Modernatx, Inc. |
Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereof
|
|
CN108473982A
(zh)
|
2015-12-24 |
2018-08-31 |
思兰克斯有限公司 |
用于蛋白生产的改进的真核细胞及其制备方法
|
|
US11136597B2
(en)
|
2016-02-16 |
2021-10-05 |
Yale University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
|
CA3014795A1
(en)
|
2016-02-16 |
2017-08-24 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
|
JP2019513371A
(ja)
*
|
2016-04-01 |
2019-05-30 |
アビディティー バイオサイエンシーズ エルエルシー |
核酸ポリペプチド組成物とその使用
|
|
CN109803687B
(zh)
|
2016-06-15 |
2022-11-15 |
耶鲁大学 |
纳米载体向肿瘤的抗体介导的自催化靶向递送
|
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
|
EP3655432A4
(en)
|
2017-07-17 |
2021-04-14 |
Nucleus Therapeutics Pty Ltd |
BINDING PROTEINS 1
|
|
US20200323964A1
(en)
|
2017-10-16 |
2020-10-15 |
Aadigen, Llc |
Peptides and nanoparticles for intracellular delivery of mrna
|
|
US12304970B2
(en)
|
2018-02-01 |
2025-05-20 |
Yale University |
Nuclear localization signals, compositions formed therefrom, and methods of use thereof for delivery of cargo to the nucleus
|
|
WO2019152808A1
(en)
|
2018-02-01 |
2019-08-08 |
Yale University |
Compositions and methods for inhibition of nuclear-penetrating antibodies
|
|
JP7570107B2
(ja)
|
2018-08-31 |
2024-10-21 |
イェール ユニバーシティー |
ドナーオリゴヌクレオチドベースの遺伝子編集を亢進するための組成物および方法
|
|
SG11202101984PA
(en)
|
2018-08-31 |
2021-03-30 |
Univ Yale |
Compositions and methods for enhancing triplex and nuclease-based gene editing
|
|
FI20186112A1
(en)
|
2018-12-19 |
2020-06-20 |
Actim Oy |
System and method for analysing a point-of-care test result
|
|
AU2020336992A1
(en)
|
2019-08-30 |
2022-04-14 |
Yale University |
Compositions and methods for delivery of nucleic acids to cells
|
|
CN111218458B
(zh)
|
2020-02-27 |
2020-11-20 |
珠海丽凡达生物技术有限公司 |
编码SARS-CoV-2病毒抗原的mRNA和疫苗及疫苗的制备方法
|
|
CA3193424A1
(en)
|
2020-08-31 |
2022-03-03 |
Yale University |
Compositions and methods for delivery of nucleic acids to cells
|
|
MX2023006403A
(es)
|
2020-12-04 |
2023-08-09 |
Gennao Bio Inc |
Composiciones y métodos para el suministro de ácidos nucleicos a las células.
|
|
WO2023168352A1
(en)
|
2022-03-03 |
2023-09-07 |
Yale University |
Humanized 3e10 antibodies, variants, and antigen binding fragments thereof
|